scholarly article | Q13442814 |
P356 | DOI | 10.1038/ONC.2013.351 |
P698 | PubMed publication ID | 23975423 |
P50 | author | Paul Hofman | Q30507739 |
Jessica Zucman-Rossi | Q43376269 | ||
Pascal Andujar | Q57334400 | ||
Françoise Le Pimpec-Barthes | Q57754127 | ||
Jean Charles Nault | Q58392544 | ||
Didier Jean | Q60380278 | ||
Marie-Claude Jaurand | Q61312611 | ||
P2093 | author name string | M-C Copin | |
A Tallet | |||
A Renier | |||
A Cazes | |||
F Galateau-Sallé | |||
I Hysi | |||
P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
Germline BAP1 mutations predispose to malignant mesothelioma | Q24635326 | ||
Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma | Q28387443 | ||
Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases | Q28389566 | ||
Highly recurrent TERT promoter mutations in human melanoma | Q29614798 | ||
TERT promoter mutations in familial and sporadic melanoma | Q29614920 | ||
Mesothelioma not associated with asbestos exposure | Q33390481 | ||
Alternative lengthening of telomeres: models, mechanisms and implications | Q34107386 | ||
p16(INK4a) -mediated suppression of telomerase in normal and malignant human breast cells | Q34137912 | ||
Regulation of the human catalytic subunit of telomerase (hTERT). | Q34180715 | ||
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma | Q34190027 | ||
Mesothelial cells: their structure, function and role in serosal repair | Q34769996 | ||
Telomerase activity in pleural malignant mesotheliomas. | Q35103570 | ||
Linking abnormal mitosis to the acquisition of DNA damage | Q36455900 | ||
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal | Q36762656 | ||
Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells | Q37164678 | ||
Human telomerase expression regulation | Q37905799 | ||
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence | Q37950784 | ||
Molecular changes in mesothelioma with an impact on prognosis and treatment | Q37988955 | ||
Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas. | Q38291755 | ||
Telomerase activity in human pleural mesothelioma | Q40818515 | ||
Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma | Q43579146 | ||
Interleukin-8 prevents oxidative stress-induced human endothelial cell senescence via telomerase activation | Q46138488 | ||
p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos | Q47988404 | ||
In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines. | Q54230847 | ||
Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma | Q60589812 | ||
Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma | Q81556073 | ||
P433 | issue | 28 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | overexpression | Q61643320 |
P304 | page(s) | 3748-3752 | |
P577 | publication date | 2013-08-26 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma | |
P478 | volume | 33 |
Q26738705 | Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications |
Q30459452 | Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer |
Q35901458 | Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis |
Q37626548 | Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma |
Q40857012 | Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness |
Q38972707 | Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles |
Q89829094 | Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival |
Q48857394 | High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression |
Q59350396 | Investigating the Promoter of FAT10 Gene in HCC Patients |
Q41335241 | KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway |
Q49232092 | Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma. |
Q64933510 | Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis. |
Q52956152 | Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer. |
Q58550783 | Not the same thing: metastatic PTCs have a different background than ATCs |
Q35001781 | Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines |
Q35068013 | TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR |
Q33688439 | TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas |
Q38232447 | Telomerase promoter mutations in cancer: an emerging molecular biomarker? |
Q53232555 | Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. |
Q91028354 | Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population |
Q54374929 | Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. |
Q55443450 | Telomere Maintenance Mechanisms in Cancer. |
Q91744753 | The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models |
Q33709979 | The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors |
Q39076273 | The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas |
Q93117015 | The role of telomeres and telomerase in cirrhosis and liver cancer |
Q26739925 | Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene |
Q33687535 | Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry? |
Q38760235 | Understanding TERT Promoter Mutations: A Common Path to Immortality. |
Search more.